On the other hand, an activating mutation in the HIF2α gene is associated with erythrocytosis and pulmonary hypertension (174, 175), which, interestingly, seems to be mostly related to a phenotypic switch of PASMC but not PAEC (176). This evidence concerns the gene EPAS1 and pulmonary hypertension.